Mitsui Chemicals Publishes 2026 Annual Report
Bitget2026/10/30 01:17- Mitsui Chemicals' 2026 annual report outlines accelerated restructuring of Basic & Green Materials, with a business split planned for fiscal 2027.
- Persistent losses in basic materials remain a priority as specialty chemicals earnings growth trails expectations.
- Decisions on underperforming businesses are due by fiscal 2026-end, while growth investment will focus on healthcare and ICT.
- Ethylene facility consolidation targets eastern Japan in 2027 and western Japan in 2030 through partnerships.
- The acquisition of Ultradent Products establishes a US healthcare platform, with growth opportunities in preventive dentistry.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Jefferies lowers SEA target price to $142
Zenix Robotics Invests 5.08 Billion Won to Expand Production Capacity
Anthropic (ANT.US) targets IPO at trillion-dollar valuation; venture capitalists warn it may signal the peak of the AI market
Venture capitalist Selby warns that Anthropic’s trillion-dollar valuation IPO could signal the peak of the AI market, and the expiration of the lock-up period may trigger a chain reaction of corrections.
Wall Street's "Great Rotation" Underway: AI Trading Fades, Tech Stocks Out of Favor, Capital Flows Shift to Defensive Sectors
Analysts point out that as investors shift their bets from high-risk technology sectors to defensive stocks, the market is currently in a "state of alert".
Crypto prices
More
